A citation-based method for searching scientific literature

Céline K Stäuble, Markus L Lampert, Samuel Allemann, Martin Hatzinger, Kurt E Hersberger, Henriette E Meyer Zu Schwabedissen, Christian Imboden, Thorsten Mikoteit. Trials 2021
Times Cited: 4







List of co-cited articles
15 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial.
Arun K Tiwari, Clement C Zai, C Anthony Altar, Julie-Anne Tanner, Paige E Davies, Paul Traxler, James Li, Elizabeth S Cogan, Matthew T Kucera, Ana Gugila,[...]. Transl Psychiatry 2022
6
50

Pharmacogenetic information in Swiss drug labels - a systematic analysis.
C Jeiziner, K Suter, U Wernli, J M Barbarino, L Gong, M Whirl-Carrillo, T E Klein, T D Szucs, K E Hersberger, H E Meyer Zu Schwabedissen. Pharmacogenomics J 2021
10
50


Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
651
50

Pharmacogenetics in Pharmaceutical Care-Piloting an Application-Oriented Blended Learning Concept.
Céline K Stäuble, Chiara Jeiziner, Kurt E Hersberger, Henriette E Meyer Zu Schwabedissen, Markus L Lampert. Pharmacy (Basel) 2021
2
100

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
Kelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, Jesse J Swen, Cyrine E Haidar, Teri E Klein, Roseann S Gammal, Mary V Relling, Stuart A Scott, Daniel L Hertz,[...]. Clin Transl Sci 2020
213
50

Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis.
Filip Milosavljevic, Nikola Bukvic, Zorana Pavlovic, Cedo Miljevic, Vesna Pešic, Espen Molden, Magnus Ingelman-Sundberg, Stefan Leucht, Marin M Jukic. JAMA Psychiatry 2021
34
50

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
290
50

Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
David W Oslin, Kevin G Lynch, Mei-Chiung Shih, Erin P Ingram, Laura O Wray, Sara R Chapman, Henry R Kranzler, Joel Gelernter, Jeffrey M Pyne, Annjanette Stone,[...]. JAMA 2022
10
50

Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility.
Paul Bradley, Michael Shiekh, Vishaal Mehra, Keith Vrbicky, Stacey Layle, Marilyn C Olson, Alejandra Maciel, Ali Cullors, Jorge A Garces, Andrew A Lukowiak. J Psychiatr Res 2018
91
50

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.
John F Greden, Sagar V Parikh, Anthony J Rothschild, Michael E Thase, Boadie W Dunlop, Charles DeBattista, Charles R Conway, Brent P Forester, Francis M Mondimore, Richard C Shelton,[...]. J Psychiatr Res 2019
122
50

Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients.
Marin M Jukić, Tore Haslemo, Espen Molden, Magnus Ingelman-Sundberg. Am J Psychiatry 2018
86
50

A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram.
Line Skute Bråten, Tore Haslemo, Marin M Jukic, Maxim Ivanov, Magnus Ingelman-Sundberg, Espen Molden, Marianne Kristiansen Kringen. Clin Pharmacol Ther 2021
16
50

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
Víctor Pérez, Ariana Salavert, Jordi Espadaler, Miquel Tuson, Jerónimo Saiz-Ruiz, Cristina Sáez-Navarro, Julio Bobes, Enrique Baca-García, Eduard Vieta, José M Olivares,[...]. BMC Psychiatry 2017
105
50

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
C Hiemke, N Bergemann, H W Clement, A Conca, J Deckert, K Domschke, G Eckermann, K Egberts, M Gerlach, C Greiner,[...]. Pharmacopsychiatry 2018
438
50

Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities.
Meghan J Chenoweth, Kathleen M Giacomini, Munir Pirmohamed, Susan L Hill, Ron H N van Schaik, Matthias Schwab, Alan R Shuldiner, Mary V Relling, Rachel F Tyndale. Clin Pharmacol Ther 2020
23
25

A Continuing Professional Development Program for Pharmacists Implementing Pharmacogenomics into Practice.
Natalie Crown, Beth A Sproule, Miles J Luke, Micheline Piquette-Miller, Lisa M McCarthy. Pharmacy (Basel) 2020
11
25

Cytochrome P450 2D6.
Ryan P Owen, Katrin Sangkuhl, Teri E Klein, Russ B Altman. Pharmacogenet Genomics 2009
76
25

PCNE definition of medication review: reaching agreement.
Nina Griese-Mammen, Kurt E Hersberger, Markus Messerli, Saija Leikola, Nejc Horvat, J W Foppe van Mil, Mitja Kos. Int J Clin Pharm 2018
86
25

Enriching Medication Review with a Pharmacogenetic Profile - A Case of Tamoxifen Adverse Drug Reactions.
Chiara Jeiziner, Céline K Stäuble, Markus L Lampert, Kurt E Hersberger, Henriette E Meyer Zu Schwabedissen. Pharmgenomics Pers Med 2021
2
50

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
C H van der Wouden, A Cambon-Thomsen, E Cecchin, K C Cheung, C L Dávila-Fajardo, V H Deneer, V Dolžan, M Ingelman-Sundberg, S Jönsson, M O Karlsson,[...]. Clin Pharmacol Ther 2017
166
25

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene.
Céline K Stäuble, Rebecca Meier, Markus L Lampert, Thorsten Mikoteit, Martin Hatzinger, Samuel S Allemann, Kurt E Hersberger, Henriette E Meyer Zu Schwabedissen. Front Psychiatry 2022
1
100

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report.
Céline K Stäuble, Markus L Lampert, Thorsten Mikoteit, Martin Hatzinger, Kurt E Hersberger, Henriette E Meyer Zu Schwabedissen. Int J Mol Sci 2021
3
33



Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
Cathelijne H van der Wouden, Paul C D Bank, Kübra Özokcu, Jesse J Swen, Henk-Jan Guchelaar. Genes (Basel) 2019
42
25

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
Tammy C Hoffmann, Paul P Glasziou, Isabelle Boutron, Ruairidh Milne, Rafael Perera, David Moher, Douglas G Altman, Virginia Barbour, Helen Macdonald, Marie Johnston,[...]. BMJ 2014
25

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting.
Céline K Stäuble, Chiara Jeiziner, Anna Bollinger, Florine M Wiss, Martin Hatzinger, Kurt E Hersberger, Thomas Ihde, Markus L Lampert, Thorsten Mikoteit, Henriette E Meyer Zu Schwabedissen,[...]. Pharmacy (Basel) 2022
1
100

Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic.
Meghan J Arwood, Eric A Dietrich, Benjamin Q Duong, D Max Smith, Kelsey Cook, Amanda Elchynski, Eric I Rosenberg, Katherine N Huber, Ying L Nagoshi, Ashleigh Wright,[...]. J Clin Med 2020
22
25

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report.
Chiara Jeiziner, Samuel S Allemann, Kurt E Hersberger, Henriette E Meyer Zu Schwabedissen. Pharmgenomics Pers Med 2022
1
100

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review.
Sylvia D Klomp, Martijn L Manson, Henk-Jan Guchelaar, Jesse J Swen. J Clin Med 2020
50
25

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report.
Céline K Stäuble, Markus L Lampert, Thorsten Mikoteit, Martin Hatzinger, Kurt E Hersberger, Henriette E Meyer Zu Schwabedissen. Life (Basel) 2021
4
25

Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B6*6 and CYP2C19*17 variants: a case report.
Céline K Stäuble, Markus L Lampert, Thorsten Mikoteit, Martin Hatzinger, Kurt E Hersberger, Henriette E Meyer Zu Schwabedissen. Pharmacogenomics 2020
5
25

Adherence in chronic disease.
J Dunbar-Jacob, J A Erlen, E A Schlenk, C M Ryan, S M Sereika, W M Doswell. Annu Rev Nurs Res 2000
168
25

Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools.
Chad A Bousman, Malcolm Forbes, Mahesh Jayaram, Harris Eyre, Charles F Reynolds, Michael Berk, Malcolm Hopwood, Chee Ng. BMC Psychiatry 2017
38
25

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
25

Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices.
Miles J Luke, Nina Krupetsky, Helen Liu, Clara Korenvain, Natalie Crown, Sameera Toenjes, Beth A Sproule, Micheline Piquette-Miller, Lisa M Guirguis, Lisa M McCarthy. Pharmacy (Basel) 2021
4
25

Practical Barriers and Facilitators Experienced by Patients, Pharmacists and Physicians to the Implementation of Pharmacogenomic Screening in Dutch Outpatient Hospital Care-An Explorative Pilot Study.
Pauline Lanting, Evelien Drenth, Ludolf Boven, Amanda van Hoek, Annemiek Hijlkema, Ellen Poot, Gerben van der Vries, Robert Schoevers, Ernst Horwitz, Reinold Gans,[...]. J Pers Med 2020
7
25

Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits.
Robert Løvsletten Smith, Kevin O'Connell, Lavinia Athanasiu, Srdjan Djurovic, Marianne Kristiansen Kringen, Ole A Andreassen, Espen Molden. Transl Psychiatry 2020
17
25

Metabolite Profiling of Clozapine in Patients Switching Versus Maintaining Treatment: A Retrospective Pilot Study.
Lennart Kyllesø, Robert Løvsletten Smith, Birgit M Wollmann, Øystein Karlstad, Ole A Andreassen, Espen Molden. J Clin Psychopharmacol 2022
1
100

Results of the CYP-GUIDES randomized controlled trial: Total cohort and primary endpoints.
Gualberto Ruaño, Saskia Robinson, Theodore Holford, Raveen Mehendru, Seth Baker, Joseph Tortora, John W Goethe. Contemp Clin Trials 2020
8
25


A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.
Changsu Han, Sheng-Min Wang, Won-Myong Bahk, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand, Laura Mandelli, Chi-Un Pae, Alessandro Serretti. Clin Psychopharmacol Neurosci 2018
21
25

Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.
Xinyu Zhou, Teng Teng, Yuqing Zhang, Cinzia Del Giovane, Toshi A Furukawa, John R Weisz, Xuemei Li, Pim Cuijpers, David Coghill, Yajie Xiang,[...]. Lancet Psychiatry 2020
85
25

Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Stefan Leucht, Alessio Crippa, Spyridon Siafis, Maxine X Patel, Nicola Orsini, John M Davis. Am J Psychiatry 2020
68
25


Pharmacogenetics at Scale: An Analysis of the UK Biobank.
Gregory McInnes, Adam Lavertu, Katrin Sangkuhl, Teri E Klein, Michelle Whirl-Carrillo, Russ B Altman. Clin Pharmacol Ther 2021
37
25

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
Heshu Abdullah-Koolmees, Antonius M van Keulen, Marga Nijenhuis, Vera H M Deneer. Front Pharmacol 2021
37
25

Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013.
Arif Khan, Kaysee Fahl Mar, Jim Faucett, Shirin Khan Schilling, Walter A Brown. World Psychiatry 2017
49
25

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.
Toshi A Furukawa, Andrea Cipriani, Philip J Cowen, Stefan Leucht, Matthias Egger, Georgia Salanti. Lancet Psychiatry 2019
112
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.